A weakness in the next session below 17,348 can drag it towards 17,160. Strength can be expected only at a close above 17,500, which should expand the rally towards 17,800,” said Mazhar Mohammad of Chartviewindia.in.The analyst advised traders to avoid long positions in the index unless it closes above 17,500.
Moderna shares soar 135% in a day after cancer vaccine succeeds in late-stage trial
Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly. This